Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nautilus Biotechnology (NAUT) Other Non-Current Assets (2020 - 2026)

Nautilus Biotechnology has reported Other Non-Current Assets over the past 7 years, most recently at $1.2 million for Q1 2026.

  • Quarterly results put Other Non-Current Assets at $1.2 million for Q1 2026, changed 0.34% from a year ago — trailing twelve months through Mar 2026 was $1.2 million (changed 0.34% YoY), and the annual figure for FY2025 was $1.2 million, changed 0.0%.
  • Other Non-Current Assets reached $1.2 million in Q1 2026 per NAUT's latest filing, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.8 million in Q2 2023 and bottomed at $997000.0 in Q1 2022.
  • Median Other Non-Current Assets over the past 5 years was $1.2 million (2023), compared with a mean of $1.2 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 77.43% in 2023 before it tumbled 33.3% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $1.1 million in 2022, then rose by 6.5% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then dropped by 0.34% to $1.2 million in 2026.
  • Business Quant data shows Other Non-Current Assets for NAUT at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.